Clinical Trial Update: A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 pilot trial investigating Technetium-99m methylene diphosphonate in the treatment of psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Psoriatic
• Psoriatic Arthritis

Drugs mentioned

• Technetium [99Tc] Methylene Diphosphonate (Technetium-99m methylene diphosphonate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Arthritis, Psoriatic | Phase 4 | Status: COMPLETED